Paper102245
Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
Wise R and 2 others. Antimicrob Agents Chemother, 1978. Cited by 37 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs. Papers, record 102245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/102245
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Cefoxitin | Major topic |
| Cephalosporins | Major topic |
| Penicillins | Major topic |
| Azlocillin | |
| Bacteroides fragilis | |
| Enterobacteriaceae | |
| Haemophilus influenzae | |
| Imidazolidines | |
| Neisseria gonorrhoeae | |
| Pseudomonas aeruginosa | |
| Staphylococcus aureus | |
| Streptococcus |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,041,216 | BL-P1654: a bacteriostatic penicillin? | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1041216 | PubMed |
| 2 | 18,083 | Azlocillin: in vitro studies of a new semisynthetic penicillin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/18083 | PubMed |
| 3 | 4,208,895 | Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. | Antimicrob Agents Chemother | 1972 | https://conductscience.org/library/papers/4208895 | PubMed |
| 4 | 4,210,893 | Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic. | Chemotherapy | 1974 | https://conductscience.org/library/papers/4210893 | PubMed |
| 5 | 810,304 | Clinical evaluation of carbenicillin in the treatment of infection due to anaerobic bacteria. | Curr Ther Res Clin Exp | 1975 | https://conductscience.org/library/papers/810304 | PubMed |
| 6 | 836,016 | Mezlocillin: in vitro studies of a new broad-spectrum penicillin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/836016 | PubMed |
| 7 | 921,239 | In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/921239 | PubMed |
| 8 | 96,726 | Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/96726 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,152,690 | Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci. | Infection | 1982 | https://conductscience.org/library/papers/7152690 | PubMed |
| 7,007,327 | Effects of furazlocillin, a beta-lactam antibiotic which binds selectively to penicillin-binding protein 3, on Escherichia coli mutants deficient in other penicillin-binding proteins. | J Bacteriol | 1981 | https://conductscience.org/library/papers/7007327 | PubMed |
| 6,875,810 | The pharmacokinetics of furazlocillin in healthy humans. | J Pharmacokinet Biopharm | 1983 | https://conductscience.org/library/papers/6875810 | PubMed |
| 6,450,748 | Evidence for involvement of penicillin-binding protein 3 in murein synthesis during septation but not during cell elongation. | J Bacteriol | 1981 | https://conductscience.org/library/papers/6450748 | PubMed |
| 6,449,903 | Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6449903 | PubMed |
| 6,448,577 | Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6448577 | PubMed |
| 6,448,229 | Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa. | Infection | 1980 | https://conductscience.org/library/papers/6448229 | PubMed |
| 6,448,020 | Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6448020 | PubMed |
| 6,391,888 | Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Drugs | 1984 | https://conductscience.org/library/papers/6391888 | PubMed |
| 6,344,786 | Selection and characterization of beta-lactam-resistant Escherichia coli K-12 mutants. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6344786 | PubMed |
| 6,321,446 | Use of ureidopenicillins for selection of plasmid vector transformants in Pseudomonas aeruginosa and Pseudomonas putida. | J Bacteriol | 1984 | https://conductscience.org/library/papers/6321446 | PubMed |
| 3,983,886 | Adverse reactions to piperacillin in adults with cystic fibrosis. | Thorax | 1985 | https://conductscience.org/library/papers/3983886 | PubMed |
| 3,729,353 | Comparative pharmacokinetics of azlocillin and piperacillin in normal adults. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3729353 | PubMed |
| 525,984 | Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/525984 | PubMed |
| 485,123 | Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/485123 | PubMed |
| 475,364 | In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/475364 | PubMed |
| 228,593 | Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/228593 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/102245
GET https://conductscience.org/api/papers/v1/102245/authors